title: 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
authors: Alberico L
authors: AL
authors: Catapano
authors: Ian
authors: I
authors: Graham
authors: Guy
authors: G
authors: De Backer
authors: Olov
authors: O
authors: Wiklund
authors: M John
authors: MJ
authors: Chapman
authors: Heinz
authors: H
authors: Drexel
authors: Arno W
authors: AW
authors: Hoes
authors: Catriona S
authors: CS
authors: Jennings
authors: Ulf
authors: U
authors: Landmesser
authors: Terje R
authors: TR
authors: Pedersen
authors: Željko
authors: Ž
authors: Reiner
authors: Gabriele
authors: G
authors: Riccardi
authors: Marja-Riita
authors: MR
authors: Taskinen
authors: Lale
authors: L
authors: Tokgozoglu
authors: W M Monique
authors: WMM
authors: Verschuren
authors: Charalambos
authors: C
authors: Vlachopoulos
authors: David A
authors: DA
authors: Wood
authors: Jose Luis
authors: JL
authors: Zamorano
authors: Marie-Therese
authors: MT
authors: Cooney
mesh_terms: D002309:Cardiology; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy*; D005060:Europe; D006801:Humans; D012306:Risk; D012737:Sex Factors; D012955:Societies, Medical
keywords: apolipoprotein B; cholesterol; dyslipidaemias; high-density lipoproteins; lipoprotein remnants; low-density lipoproteins; total cardiovascular risk; treatment, adherence; treatment, drugs; treatment, lifestyle; triglycerides